Genetic Polymorphism of SMAD5 is Associated With Kawasaki Disease
详细信息 查看全文
- 作者：Ja Hyang Cho (1)
Mi Young Han (2)
Sung Ho Cha (2)
Joo Ho Jung (3)
Kyung Lim Yoon (1) - 关键词：Mothers against decapentaplegic homolog proteins ; SMAD ; Transforming growth factor ; beta type II receptor ; TGF ; β ; Kawasaki disease ; Coronary artery lesion ; Polymorphism
- 刊名：Pediatric Cardiology
- 出版年：2014
- 出版时间：April 2014
- 年：2014
- 卷：35
- 期：4
- 页码：601-607
- 全文大小：183 KB
- 参考文献：1. Andrabi S, Bekheirnia MR, Robbins-Furman P, Lewis RA, Prior TW, Potocki L (2011) SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. Am J Med Genet A 155A:1165-169 CrossRef
2. Arj-Ong S, Thakkinstian A, McEvoy M, Attia J (2010) A systematic review and meta-analysis of tumor necrosis factor α-308 polymorphism and Kawasaki disease. Pediatr Int 52:527-32 CrossRef
3. Arjunan K, Daniels SR, Meyer RA, Schwartz DC, Barron H, Kaplan S (1986) Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. J Am Coll Cardiol 8:1119-124 CrossRef
4. Attisano L, Lee-Hoeflich ST (2001) The SMADS. Genome Biol 2:REVIEWS3010
5. Bharathy S, Xie W, Yingling JM, Reiss M (2008) Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-SMADs and invasive phenotype. Cancer Res 68:1656-666 CrossRef
6. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C et al (2009) A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet. doi:10.1371/journal.pgen.1000319
7. Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T et al (2000) Kawasaki disease: a brief history. Pediatrics 06:E27 CrossRef
8. Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H et al (2005) Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 192:344-49 CrossRef
9. Choi YM, Shim KS, Yoon KL, Han MY, Cha SH, Kim SK et al (2012) Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease. Korean J Pediatr 55:18-3 CrossRef
10. Chu MP, Wang D, Zhang YY, Li BQ, Zhou AH, Chen XW et al (2012) Pachyman treatment improves CD4+CD25+Treg counts and serum interleukin 4 and interferon γ levels in a mouse model of Kawasaki disease. Mol Med Rep 5(5):1237-240
11. Clark-Greuel JN, Connolly JM, Sorichillo E, Narula NR, Rapoport HS, Mohler ER 3rd et al (2007) Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg 83:946-53 CrossRef
12. Euler-Taimor G, Heger J (2006) The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res 69:15-5 CrossRef
13. Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J et al (2010) Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 69:194-97
14. Huang FY, Chang TY, Chen MR, Chiu NC, Chi H, Lee HC et al (2008) Genetic polymorphisms in the CD40 ligand gene and Kawasaki disease. J Clin Immunol 28:405-10 CrossRef
15. Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, Chen PJ et al (2009) Epidemiologic features of Kawasaki disease in Taiwan, 2003-006. Pediatrics 123:e401–e405 CrossRef
16. Kariyazono H, Ohno T, Khjoee V, Ihara K, Kusuhara K, Kinukawa N et al (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphism with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953-59 CrossRef
17. Kuo HC, Onouchi Y, Hsu YW, Chen WC, Huang JD, Huang YH et al (2011) Polymorphisms of transforming growth factor-β signaling pathway and Kawasaki disease in the Taiwanese population. J Hum Genet 56:840-45 CrossRef
18. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H et al (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355:788-98 CrossRef
19. Miyazono K, Kamiya Y, Morikawa M (2010) Bone morphogenetic protein receptors and signal transduction. J Biochem 147:35-1 CrossRef
20. Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y et al (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009-010 nationwide survey. J Epidemiol 22:216-21
21. Newburger JW, Burns JC (1999) Kawasaki disease. Vasc Med 4:187-02
22. Onouchi Y (2012) Genetics of Kawasaki disease: what we know and don’t know. Circ J 76:1581-586 CrossRef
23. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M et al (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35-2 CrossRef
24. Pannu H, Fadulu VT, Chang J, Lafont A, Hasham SN, Sparks E et al (2005) Mutations in transforming growth factor-β receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112:513-20 CrossRef
25. Park YW, Han JW, Hong YM, Ma JS, Cha SH, Kwon TC et al (2011) Epidemiological features of Kawasaki disease in Korea, 2006-008. Pediatr Int 53:36-9 CrossRef
26. Robinson PN, Arteaga-Solis E, Baldock C, Collod-Béroud G, Booms P, De Paepe A et al (2006) The molecular genetics of Marfan syndrome and related disorders. J Med Genet 43:769-87 CrossRef
27. Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J (2007) TGF-beta signaling in vascular fibrosis. Cardiovasc Res 74:196-06 CrossRef
28. Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D et al (2011) Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 4:16-5 CrossRef
29. Shirakawa T, Ikeda K, Nishimura S, Kuniba H, Nakashima K, Motomura H et al (2012) Lack of an association between E-selectin gene polymorphisms and risk of Kawasaki disease. Pediatr Int 54:455-60 CrossRef
30. Simonini G, Corinaldesi E, Massai C, Falcini F, Fanti F, De Martino M et al (2009) Macrophage migration inhibitory factor-173 polymorphism and risk of coronary alterations in children with Kawasaki disease. Clin Exp Rheumatol 27:1026-030
31. SMAD5?(http://www.ncbi.nlm.nih.gov/gene/4090)
32. Sun Y, Zhou J, Liao X, Lü Y, Deng C, Huang P et al (2005) Disruption of SMAD5 gene induces mitochondria-dependent apoptosis in cardiomyocytes. Exp Cell Res 306:85-3 CrossRef
33. Tsuda E, Matsuo M, Naito H, Noguchi T, Nonogi H, Echigo S (2007) Clinical features in adults with coronary arterial lesions caused by presumed Kawasaki disease. Cardiol Young 17:84-9 CrossRef
34. Umans L, Cox L, Tjwa M, Bito V, Vermeire L, Laperre K et al (2007) Inactivation of SMAD5 in endothelial cells and smooth muscle cells demonstrates that SMAD5 is required for cardiac homeostasis. Am J Pathol 170:1460-472 CrossRef
35. Van de Laar I, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM et al (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43:121-26 CrossRef
36. Wang CL, Wu YT, Liu CA, Kuo HC, Yang KD (2005) Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J 24:998-004 CrossRef
37. Wu SF, Chang JS, Peng CT, Shi YR, Tsai FJ (2004) Polymorphism of angiotensin-1 converting enzyme gene and Kawasaki disease. Pediatr Cardiol 25:529-33 CrossRef
38. Yasukawa K, Terai M, Shulman ST, Toyozaki T, Yajima S, Kohno Y et al (2002) Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation 105:766-69 CrossRef - 作者单位：Ja Hyang Cho (1)
Mi Young Han (2)
Sung Ho Cha (2)
Joo Ho Jung (3)
Kyung Lim Yoon (1)
1. Department of Pediatrics, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gandong-gu, Seoul, 137-727, Korea
2. Department of Pediatrics, Kyung Hee University Medical Center, Seoul, Korea
3. Department of Clinical Pharmacology, Kyung Hee University School of Medicine, Seoul, Korea - ISSN：1432-1971
文摘
Mothers against decapentaplegic homolog (SMAD) proteins are intracellular mediators of members of the transforming growth factor-β (TGF-β) superfamily, which are activated by bone morphogenetic proteins (BMPs). On activation, SMAD5 forms heterometric SMAD complexes, which are translated to the nucleus where they regulate gene transcription. TGF-β induces T cell activation and cardiovascular disease, two important features of Kawasaki disease (KD), whereas BMP is associated with coronary artery disease. In this study, we hypothesized that single nucleotide polymorphisms (SNPs) of SMAD5 may be associated with KD and coronary arterial lesions (CALs). Genotyping for 15 SNPs of the SMAD5 gene (rs3764941, rs10085013, rs6596284, rs7356756, rs13179769, rs13166063, rs1109158, rs4585442, rs4146185, rs12719481, rs6865297, rs3206634, rs6871224, rs1057898, and rs7031) was performed by direct sequencing of 105 KD patients and 303 healthy adult controls. We also compared the allele frequencies between a CAL group (n?=?31) and a normal coronary group (n?=?74). Results showed that among the 15 SNPs, rs3206634 was significantly associated with KD in a recessive model (odds ratio?=?2.31, p?=?0.019), whereas there was no association between any of the 15 SNPs and CALs. These findings may be used as a risk factors development of KD or for future generations of therapeutic treatments for KD.